Therefore, a TCGA analysis and immunohistochemistry, including tumor tissue from patients before and after neoadjuvant treatment, was performed to investigate the prognostic role of expression of FGF8, FGF18, and FGFR4 in adenocarcinomas of the esophago-gastric junction. Here, FGF18 is linked to neoplasm.